Latest Prostate cancer Stories
VANCOUVER, Jan. 26, 2015 /PRNewswire/ - ESSA Pharma Inc.
BETHESDA, Md., Jan. 23, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)("NW Bio"), a U.S.
QUEBEC CITY, Jan. 23, 2015 /PRNewswire/ - DiagnoCure, Inc.
The pilot study is designed to assess whether VolitionRx's NuQ® assays could be used as an initial screening tool for ovarian cancer NAMUR, Belgium, Jan.
First-in-Class Agent is Well Tolerated in Liver Cancer Patients SAN ANTONIO, Jan.
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash. and VANCOUVER, British Columbia, Jan.
UNC Urology and Affiliates to leverage RegistryMetrix Analytics Platform ANN ARBOR, Mich., Jan.
Decipher is the first genomic test for postoperative prostate cancer to gain Medicare coverage SAN DIEGO, Jan.
PCF's 2014 Research Programs Reach $39 Million SANTA MONICA, Calif., Jan.
More Images (2 images) »